Japanese Journal of Radiation Safety Management
Online ISSN : 1884-9512
Print ISSN : 1347-1503
ISSN-L : 1347-1503
Current issue
Showing 1-5 articles out of 5 articles from the selected issue
Case report
  • Kotaro NAGATSU, Naoyuki UKON, Takahiro YAMADA, Makoto HOSONO
    2019 Volume 18 Issue 2 Pages 36-40
    Published: 2019
    Released: November 12, 2019

     Our country has many advances in the use of diagnostic radiopharmaceuticals; however, it should be said that the therapeutic nuclear medicine in both fields of research and clinical are still in developing stage compared to those seen in other countries. Now that alpha-emitters, conventionally regarded as an ‘dangerous stuff’, are being applied to the ‘targeted radionuclide therapy (TRT)’ worldwide. In Japan, a need of reviewing for radiation safety management is thus emerged to handle the alpha-emitters at a viewpoint of scientifically rational. This is a summary on such management applied in the University of Gothenburg in Sweden, where advanced practices of using alpha-emitters are being made for a long time in the therapeutic nuclear medicine. Although we have no intension of blindly accepting those management systems valid in other countries, it would be delightful if this report is referred to discuss and reinforce rational regulations in Japan.

    Download PDF (683K)
Proceeding of 16th JRSM Symposium on June (Tokyo)